PHYSICAL TRAINING & ADRENERGIC RECEPTORS IN HYPERTENSION
PHYSICAL TRAINING & ADRENERGIC RECEPTORS IN HYPERTENSION
批准号:
3422335
负责人:
MICHAEL A BERK
金额:
$2.24万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-07-01 至 1986-06-30
中文摘要
原发性高血压,占全部的90%以上
英文摘要
Essential hypertension, accounting for greater than 90% of all
hypertension, affects between 15 and 20% of all adults and is a significant
risk factor for excess morbidity and mortality due to arteriosclerotic and
cerebrovascular disease. Reduction of even mild hypertension has been
shown to decrease long-term morbidity and mortality due to vascular
disease. Excess sympathetic nervous system activity has been postulated as
an etiologic factor in essential hypertension but direct measurement of
circulating plasma norepinephrine and epinephrine levels as an indicator of
sympathetic dysfunction has been equivocal. Direct studies of adrenergic
receptor-effector mechanisms in essential hypertension have been scant but
are suggestive of a generalized receptor-effector abnormality in
hypertensive subjects.
The present study is designed to study the effects of physical training, a
modality known to reduce sympathetic activity, on adrenergic-receptor
effector mechanisms and their relationship to blood pressure.
Beta-2 and alpha-2 adrenergic receptors will be measured on circulating
mononuclear leukocytes and platelets, respectively, in untreated
hypertensive subjects (n=10) and matched normal controls (n=10) at
baseline, after a one-month period with no therapy and after 12 weeks of
bicycle ergometer exercise at 60% maximal oxygen consumption for 30
minutes, three times per week. Receptor studies will include standard
saturation curves to measure apparent dissociation constant (Kd) and
receptor density (Beta max). Beta-2 receptors will be measured with
Iodocycopindolol-125, a Beta antagonist, an Alpha-2 receptors with
[H-3]-UK-14304, an Alpha-2 agonist. In addition, competition studies will
be done in the presence and absence of Gpp(NH)p to determine the percentage
of receptors in high and low affinity binding states. Adenylate cyclase
activity in response to isoproterenal stimulation (Beta-2) and epinephrine
inhibition (Alpha-2) will also be done. It is expected that 1)
hypertensive subjects will exhibit altered adrenergic receptor status when
compared to normal controls that will correct after physical training and
2) correction of receptor abnormality will be correlated with a decrease in
blood pressure.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HYPOGLYCEMIA, MATERNAL AND PERINATAL MORBIDITY
-
批准号:3884203
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL A BERK
-
依托单位:
EFFECTS OF PREGNANCY ON DIABETIC MICROVASCULAR DISEASE
-
批准号:3878443
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL A BERK
-
依托单位:
EFFECTS OF PREGNANCY ON DIABETIC MICROVASCULAR DISEASE
-
批准号:3857397
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL A BERK
-
依托单位:
HYPOGLYCEMIA--MATERNAL AND PERINATAL MORTALITY
-
批准号:3778863
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL A BERK
-
依托单位:
HYPOGLYCEMIA, MATERNAL AND PERINATAL MORTALITY
-
批准号:3857394
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL A BERK
-
依托单位:
EFFECTS OF PREGNANCY ON DIABETIC MICROVASCULAR DISEASE
-
批准号:3756970
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL A BERK
-
依托单位:
HYPOGLYCEMIA--MATERNAL AND PERINATAL MORTALITY
-
批准号:3756967
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL A BERK
-
依托单位:
HYPOGLYCEMIA--MATERNAL AND PERINATAL MORTALITY
-
批准号:3842623
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL A BERK
-
依托单位:
EFFECTS OF PREGNANCY ON DIABETIC MICROVASCULAR DISEASE
-
批准号:3842626
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL A BERK
-
依托单位:
HYPOGLYCEMIA, MATERNAL AND PERINATAL MORTALITY
-
批准号:3878440
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL A BERK
-
依托单位:
EFFECTS OF PREGNANCY ON DIABETIC MICROVASCULAR DISEASE
-
批准号:3778866
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL A BERK
-
依托单位:
海外基金